Blog

(268-4) Pembrolizumab receives FDA approval for people with early-stage, triple-negative breast cancer

[force_feed_single article=”268″]

Update: Pembrolizumab receives FDA approval for people with early-stage, triple-negative breast cancer

[force_feed_single article=”268″]

Is your Grants.gov registration up to date?

Is your Grants.gov registration up to date? If not, you are missing out on millions of dollars in funding. As of June 11th, SAM.gov registration requires entities to submit a notarized letter appointing the authorized Entity Administrator. The acceptance of this letter takes a couple of weeks and not having it on file will prevent […]

Training • Planning • Communications • Implementation